Press SAMHSA to immediately rescind its April 24, 2026 guidance barring grant recipients from purchasing or distributing harm-reduction tools such as syringes and fentanyl or xylazine test strips, and restore grantees' ability to use those tools to prevent harm.

We call on you to immediately rescind the April 24 Dear Colleague letter and restore grantees’ ability to use the best available tools to prevent unnecessary harm.

Markey and other lawmakers urged SAMHSA to reverse its new guidance restricting grant recipients from using federal funds for harm-reduction tools and to restore access to those tools.

5.8.26 Markey Letter to SAMHSA
primary · other · model gpt-5.5

Markey led a bipartisan letter to SAMHSA urging it to reverse the April 24 Dear Colleague guidance and restore grantees' ability to use fentanyl/xylazine test strips and syringes.

Direct official proof that Markey pressed SAMHSA to rescind the guidance.

delivered same_term A for effort

5.8.26 Markey Letter to SAMHSA
primary · model gpt-5.4-mini · confidence 98%

SAMHSA's Dear Colleague page still listed 'Updated Funding Guidance for Grantees on Supplies and Services' as of its May 13, 2026 update.

Official agency page indicates the April 24 guidance was still posted at the last recorded update, so rescission was not shown.

unresolved same_term

Dear Colleague Letters | SAMHSA
secondary · model gpt-5.4-mini · confidence 82%